SmartMatch: could a lab test find the right drug for your brain tumor?

This study is testing a new technology called SmartMatch that analyzes tumor tissue from people with recurrent brain or spinal cord tumors. The goal is to see if SmartMatch can quickly identify which drugs might work best for each person's specific tumor. About 80 participants aged 15 and older who are already scheduled for surgery will provide a small tumor sample. The results may help guide treatment decisions, but there is no guarantee of benefit.